Retour à la liste des essais cliniquesCancers gynécologiques

RAINBO

Refining Adjuvant treatment IN endometrial cancer Based On molecular features, TransPORTEC platform trials · p53abn - RED.

Ouvert à Paris depuis le : 31/10/2024
Public cible : Adult
Phase : Phase III

Description de l'essai

To assess whether maintenance therapy with olaparib improves recurrence-free survival (RFS), as compared to observation after chemo-radiotherapy in patients with p53abn HREC.

Url of the trial

Investigateur principal

AUDREY BELLESOEUR

Médecin

Contacter